CRP and lymphopenia: We sought to test the hypothesis that lymphopenia may identify a population at enhanced risk, and those with multiple immunohematologic (IH) abnormalities (defined herein as lymphopenia and/or abnormal RDW or CRP levels) may have further reduced longevity.